Baird lowered the firm’s price target on Regeneron (REGN) to $652 from $759 and keeps a Neutral rating on the shares. The firm said its Eylea ...

Dimensional Fund Advisors LP boosted its stake in Regeneron Pharmaceuticals by 3% in Q4, totaling over $418 million in ...

FujiFilm Diosynth plans to produce Regeneron's biologic medicines over 10 years in its Holly Springs facility, which is scheduled to begin operations this year.

Ahead of its scheduled opening later this year, the massive Fujifilm Diosynth Biotechnologies manufacturing plant in Holly Springs has added a new customer in a lucrative deal. On Tuesday, Fujifilm ...

Marvel Rivals is a competitive game set in the multiverse, so it’s fitting that you play on a number of different maps. There are also two arcade modes and maps, which offer a different gameplay ...

Social media interventions significantly improved follow-up adherence and parental knowledge in congenital ectopia lentis cases. Congenital ectopia lentis, often linked to fibrillinopathies, requires ...

Raheen College Transition Year student Avaneesh Kilkarne’s project, Neuro Pulse, was one of the 23 finalists in the BD STEMS Stars contest at the American medical technology multi-national’s Research ...

Investors in Regeneron Pharmaceuticals, Inc. (Symbol: REGN) saw new options become available today, for the May 30th expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

Shares of some drugmakers rose on Wednesday after President Donald Trump said he would pause steep tariff rates on dozens of countries, temporarily easing fears about the impact of potential ...

As you can see from the chart above the percentage of shares that are sold short for Regeneron Pharmaceuticals has grown since its last report. This does not mean that the stock is going to fall ...

Macy Meyer is a North Carolina native who graduated from UNC-Chapel Hill with a BA in English and a second BA in Journalism. Macy is a Writer on the CNET How-To team, covering a variety of topics ...